Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Apr 27;290(6477):1246–1248. doi: 10.1136/bmj.290.6477.1246

Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.

K G Power, D W Jerrom, R J Simpson, M Mitchell
PMCID: PMC1415890  PMID: 3921173

Abstract

A group of patients suffering from anxiety, as assessed by general practitioners and psychologists using research criteria for generalised anxiety, were treated with either diazepam or placebo double blind for six weeks. This active treatment period was preceded by a one week single blind placebo "wash in" period and followed by a two week single blind placebo "wash out" period. The results suggest that diazepam can produce rebound anxiety and withdrawal symptoms when used in moderate doses and for what has previously been regarded as a safe length of time. If replicated these results have implications for the therapeutic use of benzodiazepines.

Full text

PDF
1246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fontaine R., Chouinard G., Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry. 1984 Jul;141(7):848–852. doi: 10.1176/ajp.141.7.848. [DOI] [PubMed] [Google Scholar]
  2. HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x. [DOI] [PubMed] [Google Scholar]
  3. Hallstrom C., Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry. 1981;16(4):235–244. doi: 10.1159/000468500. [DOI] [PubMed] [Google Scholar]
  4. Kellner R., Sheffield B. F. A self-rating scale of distress. Psychol Med. 1973 Feb;3(1):88–100. doi: 10.1017/s0033291700046377. [DOI] [PubMed] [Google Scholar]
  5. Miller F., Nulsen J. Single case study. Diazepam (Valium) detoxification. J Nerv Ment Dis. 1979 Oct;167(10):637–638. doi: 10.1097/00005053-197910000-00010. [DOI] [PubMed] [Google Scholar]
  6. Owen R. T., Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs. 1983 Apr;25(4):385–398. doi: 10.2165/00003495-198325040-00003. [DOI] [PubMed] [Google Scholar]
  7. Pesce A., Rossi F., Valeri P. Effetti collaterali delle benzodiazepine: l'ansia e l'insonnia di "rimbalzo". Clin Ter. 1981 Dec 15;99(5):461–470. [PubMed] [Google Scholar]
  8. Petursson H., Lader M. H. Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) 1981 Sep 5;283(6292):643–645. doi: 10.1136/bmj.283.6292.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Shapiro A. K., Struening E. L., Shapiro E., Milcarek B. I. Diazepam: how much better than placebo? J Psychiatr Res. 1982;17(1):51–73. doi: 10.1016/0022-3956(82)90034-6. [DOI] [PubMed] [Google Scholar]
  10. Skegg D. C., Doll R., Perry J. Use of medicines in general practice. Br Med J. 1977 Jun 18;1(6076):1561–1563. doi: 10.1136/bmj.1.6076.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tyrer P. J. Benzodiazepines on trial. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1101–1102. doi: 10.1136/bmj.288.6424.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tyrer P., Owen R. Anxiety in primary care: is short-term drug treatment appropriate? J Psychiatr Res. 1984;18(1):73–78. doi: 10.1016/0022-3956(84)90048-7. [DOI] [PubMed] [Google Scholar]
  13. Winokur A., Rickels K., Greenblatt D. J., Snyder P. J., Schatz N. J. Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. Arch Gen Psychiatry. 1980 Jan;37(1):101–105. doi: 10.1001/archpsyc.1980.01780140103012. [DOI] [PubMed] [Google Scholar]
  14. de Bard M. L. Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma. Am J Psychiatry. 1979 Jan;136(1):104–105. doi: 10.1176/ajp.136.1.104. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES